Healome Therapeutics is an ophthalmology and ocular drug delivery company aiming to improve the safety, effectiveness, and usability of ocular drugs and treatment of ocular surface conditions. 

Eye drops as a therapeutic approach has enabled people to administer therapeutics anywhere and at anytime. However, conventional eye drops clear from the ocular surface in minutes. Healome has developed an eye drop matrix technology  behaves like a liquid when it is dropped on the eye, and then restructures on the eye to form a clear, lubricating, protective matrix. The matrix can also deliver a broad range of drugs, from small molecules to complex biologics.

​While we strive to transform eye care over the longer-term, we are committed to improving the field in the near-term as well. Using our technology, we aim to enhance the therapeutic value of existing ocular medicines through reformulation, and develop novel therapeutics that could transform the management of ocular surface health.